Extrahepatic manifestations of hepatitis C virus

Current Gastroenterology Reports

Volumn 8, Issue 1, 2006, Pages 53-59

  Sterling, Richard K ^a   Bralow, S Philip ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; CORTICOSTEROID; CRYOGLOBULIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DEFEROXAMINE; INTERFERON; RIBAVIRIN;

ARTHRALGIA; CHRONIC DISEASE; CLINICAL FEATURE; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; FATIGUE; GASTROENTEROLOGY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY DISEASE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LOW DRUG DOSE; LYMPHOMA; MEDICAL SPECIALIST; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PLASMAPHERESIS; PORPHYRIA CUTANEA TARDA; PREVALENCE; REVIEW; SJOEGREN SYNDROME; SKIN DISEASE; SYSTEMIC VASCULITIS; THYROID DISEASE;

CRYOGLOBULINEMIA; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; KIDNEY DISEASES; LYMPHOMA; NERVOUS SYSTEM DISEASES; PORPHYRIA CUTANEA TARDA; RHEUMATIC DISEASES; SJOGREN'S SYNDROME; SKIN DISEASES; VASCULITIS;

EID: 33645067930     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-006-0064-y     Document Type: Review

References (35)

1. Sene D, Limal N, Cacoub P: Hepatitis C virus-associated Extrahepatic manifestations; a review. Metabol Brain Dis 2004, 19:357-438.
2. Bonkovsky HL, Mehta S: Hepatitis C: A review and update. J Am Acad Dermatol 2001, 44:159-182.
3. Lauer GM, Walker BD: Hepatitis C virus Infection. N Engl J Med 2001, 345:41-52.
4. Agnella V, DeRosa F: Extrahepatic disease manifestations of HCV Infection: some current issues. J Hepatol 2004, 40:341-352.
5. Cacoub P, Ratziu V, Myers RP, et al.: Impact of treatment on extrahepatic manifestations in patients with chronic hepatitis C. J Hepatol 2002, 30:812-818.
6. Willson RA: Extrahepatic manifestations of viral hepatitis. Am J Gastroenterol 1997, 92:4-17.
7. Mehta S, Levey JM, Bonkovsky HL: Extrahepatic manifestations of infection with hepatitis C virus. Clin Liver Dis 2001, 5:1-21.
8. Mayo MJ: Extrahepatic manifestations of hepatitis C infection, Southwest. Int Med Conf 2002, 325:135-148.
9. Meltzer M, Franklin BC, McClusky EK, Cooper N: Cryoglobulinemia: a clinical and laboratory study-type 2 cryoglobulins with rheumatoid factor activity. Am J Med 1966, 40:837-856.
10. Johnson RJ, Willson R, Yamabe H, et al.: Renal manifestations of chronic hepatitis C virus. Kidney International 1994, 46:1255-1263.
11. Frangeul AL, Musset L, Cresta P, et al.: Hepatitis C virus genotypes and subtypes in patients with hepatitis C with and without cryoglobulinemia. J Hepatol 1996, 251:427-432.
12. Cacoub P, Renou C, Rosenthal E, et al.: Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. Medicine 2000, 79:47-56.
13. Sterling RK, Gehr T: Renal involvement in liver disease. In Hepatology: A Practical Approach. Edited by Knawy BA, Shiffman ML, Wiesner RH: Amsterdam: Elsevier; 2004:443-453.
14. Johonson RJ, Gretch DR, Yamabe H, et al.: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. New Engl J Med 1993, 328:465-470.
15. Hermine O, Lefrere F, Bronowicki JP, et al.: Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 2002, 347:89-94.
16. Kitay-Cohen Y, Amiel A, Hilzenrat N, et al.: Bcl-2 rearrangement in patients with chronic hepatitis C with essential mixed cryoglobilinemia. Blood 2000, 96:2910-2912.
17. Zuckerman E, Zuckerman T, Levine AM, et al.: Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma. Ann Int Med 1997, 127:423-428.
18. Haddad J, Deny P, Munz-Gotheil C, et al.: Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C liver disease. Lancet 1992, 339:321-333.
19. Loustaud-Ratti V, Riche A, Liozone E, Labrousse F, et al.: Prevalence and characteristics of Sjogren's syndrome or sicca syndrome in chronic hepatitis C virus infection: a prospective study. J Rheumatol 2201, 28:2245-2251.
20. Verban H, Carlson J, Eriksson S, et al.: Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjogren's syndrome and hepatitis C in Swedish patients. J Int Med 1999, 245: 127-132.
21. Koike K, Moriye K, Ishibashi K, et al.: Sialadenitis histologically resembling Sjogren's syndrome in mice transgenic for hepatitis C virus envelop genes. Proc Natl Acad Sci U S A 1997, 94:233-236.
22. Gisbert JP, Garcia-Buey L, Parjares JM, Moreno-Otero R: Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis. J Hepatology 2003, 39:620-627.
23. Dienhart PWM, Sterling RK: Management of hepatitis C virus in patients with porphyria cutanea tarda. Curr Hepatitis Rep 2005, in press.
24. Sankany RP: The management of porphyria cutanea tarda. Clin Exp Dermatol 2001, 26:225-232.
25. Bonkovsky HL, Poh-Fitzpatrick M, Primstone N, et al.: Porphyria cutanea tarda, hepatitis C and HFE gene mutations in North America. Hepatology 1998, 27:1661-1669.
26. Linet MS, Gridley G, Nyren O, et al.: Primary liver cancer, other malignancies and mortality risks following porphyria: a cohort study in Denmark and Sweden. Am J Epidemiol 1999, 149:1010-1015.
27. Lamoril J, Andant C, Bogard et al.: Epidemiology of hepatitis C and G in sporadic and familial porphyria cutanea tarda. Hepatology 1998, 27:848-852.
28. Chuang TY, Brashear R, Lewis C: Porphyria cutanea tarda and hepatitis C virus: a case control study and meta-analysis of the literature. J Am Acad Dermatol 1999, 41:31-36.
29. Hernandez F, Blanquer A, Linares M, Lopez A, et al.: Autoimmune thrombocytopenia associated with hepatitis C virus infection. Acta Haematol 1998, 99:217-220.
30. Nagamine T, Ohtuka T, Takahara K, et al.: Thrombocytopenia associated with hepatitis C viral infection. J Hepatol 1996, 24:135-140.
31. Arao M, Murase K, Kusakabe A, Yoshioka K, et al.: Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus. J Gastroenterol 2003, 38:355-360.
32. Caronia S, Taylor K, Pagliaro L, et al.: Further evidence for an association between non-insulin dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999, 30:1059-1063.
33. Antonelli A, Ferri C, Pampana A, et al.: Thyroid disorders in chronic hepatitis C. Am J Med 2004, 117:10-13.
34. Frider B, Sookian S, Castano G, et al.: Lichen planus, chronic hepatitis C and interferon. Hepatology 1995, 21:1764-1765.
35. Mignogna MD, Muzio LL, Favia G, et al.: Oral lichen planus and HCV infection: a clinical evaluation of 263 cases. Int J Dermatol 1998, 37:575-578.